Boston Scientific won approval from the FDA and is launching its Resonate line of implantable cardioverter defibrillators (ICD) and cardiac resynchronization therapy defibrillators (CRT-D). The implants include the firm’s HeartLogic diagnostic capability that sends an alarm to the cardiologist if it believes the patient’s heart is exhi (Read more...)